China Medicine Corporation Announces Conference Call to Discuss First Quarter 2009 Results

GUANGZHOU, China, May 6 /PRNewswire-Asia/ -- China Medicine Corporation (“China Medicine” or “the Company”), a developer and a leading distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, and medical devices and medical formulations, today announced that it will conduct a conference call at 9:00 a.m. Eastern Time on Wednesday, May 13, 2009, to discuss its first quarter 2009 results.

Joining Mr. Senshan Yang, Chairman and Chief Executive Officer of China Medicine Corporation, will be Ms. Huizhen Yu, Chief Financial Officer. The Company plans to make an earnings announcement prior to the call.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 888.419.5570. International callers should dial 617.896.9871, Conference Passcode: 991 874 58.

If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Wednesday, May 13, at 11:00 a.m. Eastern Time. To access the replay, dial 888.286.8010, international callers dial 617.801.6888, and enter the passcode of 460 255 05.

About China Medicine Corporation

China Medicine Corporation is a developer and leading distributor of prescription and over the counter (“OTC”) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine also has its research and development force for certain products it manufactures through OEM arrangement makes the distribution. The Company distributes its products to wholesale distributors including more than 300 hospitals and 500 medicine companies that sell to over 2,000 drug stores in 28 provinces throughout China. The Company actively develops a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company’s website at http://www.chinamedicinecorp.com

CONTACT: Huizhen Yu, Chief Financial Officer, China Medicine Corporation
at +86-20-8739-1718 or konzern08@163.com ; or Crocker Coulson, President,
CCG Investor Relations at +1-646-213-1915 or crocker.coulson@ccgir.com

Web site: http://www.chinamedicinecorp.com/
http://www.ccgirasia.com/

MORE ON THIS TOPIC